FDA approves Olaparib Plus Abiraterone and Prednisone or Prednisolone for BRCA-mutated metastatic castration-resistant prostate cancer
adminBy the staff of ASCO PostPosted: 2/6/2023 12:43:00 Last update: 6/2/2023 12:38:22 On May 31, the U.S. Food and Drug Administration (FDA) approved olaparib (Lynparza) in combination with abiraterone and…